首页> 外文期刊>The Canadian journal of hospital pharmacy. >A Comparative Study of the Conformity of the Documentation of Drug Doses Administered Pre and Post Implementation of an Electronic Medication Record
【24h】

A Comparative Study of the Conformity of the Documentation of Drug Doses Administered Pre and Post Implementation of an Electronic Medication Record

机译:药物剂量文件符合的比较研究给药前和后期电子药物记录

获取原文
获取原文并翻译 | 示例
       

摘要

Background: There is a growing need for better documentation of drug doses in patient records, including higher traceability of steps performed by healthcare professionals. Electronic medication administration records (eMAR) are expected to increase the documentation of drug administration. Objectives: To compare the conformity of the documentation of drug doses administered pre-post implantation of an eMAR Methods: This retrospective pre-post study was conducted in a 45-bed pediatric surgery unit. The pre-implementation phase occurred between October 19~th-26~th, 2014. The post-implementaion phase occurred between May 3rd-14~th, 2015. Medication administration records were extracted from the digitalized patient healthcare record (Chartmax?). We compared the documented steps for each planned drug administration. A chi square test was used to compare conformity. We calculated the ratio of the number of steps documented on the number of steps that should be documented. Results: A total of 135 patient charts were consulted. A total 4157 doses (2551 pre-implementation, 1606 post-implementation) were included. They represented 543 regular drug orders (280 pre-implementation, 263 post-implementation), 388 as needed drug orders (260 pre-implementation, 128 post-implementation). Post-implementation, the conformity of the documentation of drug dose administered increased from 79.5% (689/867) to 88.1% (796/904) (p < 0.0001) for regular drug doses and from 16.3% (272/1665) to 43.5% (298/685) for as needed drug doses (p < 0.0001). The ratio of steps documented increased from 0.40 to 0.56 for regular drug doses and from 0.13 to 0.28 for as needed drug doses. However, for drug infusions (n= 19 doses pre-implementation, n= 17 doses post-implementation), it decreased from 0.63 to 0.51. Conclusions: This study showed an increase in conformity of the documentation of drug doses administered pre and post implementation of an eMAR. While eMAR can contribute to better documentation and traceability, further gain relies on human factor, enforcement of policy and procedures and periodical practice audits.
机译:背景:在患者记录中,越来越需要更好地文献药物剂量,包括较高的保健专业人士进行的步骤可追溯性。预计电子药物管理记录(EMAR)将增加药物管理局的文件。目的:比较药物剂量文件的符合性,给药后植入前植入的EMAR方法:该回顾性预研究是在45床儿科手术单元中进行的。预先实施阶段发生在10月19日〜Th-26〜Th,2014年之间。在2015年5月3日至14日之间发生的后级阶段。从数字化患者医疗保健记录中提取药物管理记录(Chartmax?)。我们比较了每个计划药物管理局的记录步骤。 CHI方检验用于比较一致性。我们计算了记录在应记录的步数上记录的步数的比率。结果:咨询了135名患者图表。总共4157剂(2551次预先实施,1606次实施)。它们代表了543次常规药物订单(280个预先实施,263次实施),388,必要的药物订单(260前实施,实施后128个)。后实施后,药物剂量文件的符合性从79.5%(689/867)增加到88.1%(796/904)(p <0.0001),用于常规药物剂量,16.3%(272/1665)至43.5 %(298/685),根据需要的药物剂量(p <0.0001)。记录的步骤的比例从0.40〜0.56增加,常规药物剂量和0.13至0.28,根据需要的药物剂量。然而,对于药物输注(n = 19剂预先实现,N = 17剂量后,实施后,它从0.63降至0.51。结论:该研究表明,药物剂量的文件符合符合性的增加,施用emar的前后实施。虽然EMAR可以有助于更好的文件和可追溯性,但进一步依赖于人为因素,政策和程序的执行以及定期练习审计。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号